Gov. JB Pritzker supports a proposal that would require pharmacy benefit managers to change how they do business.

Executive order on prescription drug pricing supports key drug industry efforts to weaken the Medicare negotiation program.

An EO signed on April 15th is a solid first step toward improving drug affordability without diminishing the hope of patients ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

The generic drug industry has warned that US tariffs on pharmaceuticals risk causing shortages of medicines including cancer ...

Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of ...

People taking GLP-1s consumed less processed food, although they still craved it. As a growing number of people using ...

Sanofi India is divesting its insulin brand, Lantus, with Glenmark, Dr. Reddy's, and Emcure Pharma considering acquisition, ...

Popular Western medicines for diseases including cancer and diabetes have been caught in the escalating U.S.-China trade war, ...

In 2024, the FDA's Center for Drug Evaluation and Research (CDER) approved 50 new drugs. The CDER director, Patrizia ...

Pfizer’s decision to discontinue development of danuglipron is a big event for the obesity treatment market. As an oral drug, danuglipron ... which is under the industry’s average price ...

Similarly, Bristol Myers Squibb's acquisition of Turning Point Therapeutics aimed at bolstering its precision medicine portfolio highlights the strategic maneuvers within the industry. The thyroid ...